Banco Santander Chile
Pillar III Market
Discipline and
Transparency
December 30, 2023
Pillar III - 2Q2023 | |||
Index | |||
LI1 - Differences between the accoun ng and regulatory consolida on perimeters and | |||
their correspondence between financial statements and regulatory risk categories | 4 | ||
LI2 -Main sources of discrepancy between regulatory exposures amounts and book values | |||
in the financial statements | 5 | ||
KM1 - Key Parameters | 6 | ||
OV1 - RWA Presenta on | ......................................................................................................... | 7 | |
CC1 - Composi | on of Regulatory Capital (Part 1) | 8 | |
CC1 - Composi | on of Regulatory Capital (Part 2) | 9 | |
CC2 - Reconcilia | on of Regulatory Capital to Balance Sheet (Part 1) | 11 | |
CC2 - Reconcilia | on of Regulatory Capital to Balance Sheet (Part 2) | 12 | |
CCA - Main Characteris | cs of Regulatory Capital Instruments (Part 1) | 13 | |
CCA - Main Characteris | cs of Regulatory Capital Instruments (Part 2) | 14 | |
CCA - Main Characteris | cs of Regulatory Capital Instruments (Part 3) | 15 | |
LR1 - Compara | ve Summary of Accoun ng Assets vs. Leverage Ra o Exposure Measure. 16 | ||
LR2 - Summary of Leverage Ra o Exposure Measure | 17 | ||
CDC - Restric ons on the ability to distribute capital | 18 | ||
CR1 - Credit Quality of Assets | 19 | ||
CR2 - Changes in the stock of loans and non-deriva ve financial instruments in the default | |||
banking book | 20 | ||
CR3 - Credit Risk Mi ga | on Techniques (CRM): Overview | 21 | |
CR4 - Standard Approach: CR Exposure and CRM Effects | 22 | ||
CR5 - Standardized Approach: Exposures by Type of Counterparty and Weights by RC | 23 | ||
CCR1 - Analysis of CCR Exposures by Approach | 24 | ||
CCR3 - Standardized Approach for CCR Exposures by Type of Counterparty and Risk | |||
Weights | 25 | ||
CCR5 - Collateral Composi on for CCR Exposures | 26 | ||
CCR8 - Exposures to Central Counterpar es | 27 | ||
MR1 - Market Risk Under Standardised Approach | 28 | ||
RMLB1 - Quan ta ve informa on on IRRBB | 29 | ||
OR1 - Historical losses | 30 | ||
OR2 - Business indicator (BI) and subcomponents | 31 | ||
OR3 - Minimum capital requirement for opera onal risk | 32 | ||
LIQ1 - Liquidity Coverage Ra o (LCR) | 33 | ||
2 |
Pillar III - 2Q2023 | ||
LIQ2 - Net Stable Funding Ra | o (NSFR) | 34 |
ENC - Encumbered Assets | 35 | |
REM1 - Compensa on paid during the financial year | 36 | |
REM2 - Extraordinary payments | 37 | |
................................................................................................. | ¡Error! Marcador no definido. | |
REM3 - deferred compensa | on | 38 |
.............................................................................................................................................. | 38 |
Notas
- La información relativa a Pilar III se publica de forma independiente en la web de Santander.
- Banco Santander Chile no cuenta con metodologías internas para el cálculo de los Activos Ponderados por Riesgo de Crédito de acuerdo al Capítulo 21-6 de la RAN, por lo tanto las tablas CR6, CR8, CCR4, CMS1 y CMS2 no aplican para este caso.
- Las tablas SEC1, SEC2, SEC3 y SEC4 tampoco aplican para Banco Santander Chile, ya que el Banco no mantiene securitizaciones en nombre propio a la fecha del reporte.
- La información se muestra a nivel consolidado. El perímetro consolidado local y consolidado global es coincidente, puesto que no existen filiales en el extranjero.
3
Pillar III - 2Q2023
LI1- Differences between the accoun ng and regulatory consolida on perimeters and their correspondence between financial statements and regulatory risk categories
4
Pillar III - 2Q2023
LI2-Main sources of discrepancy between regulatory exposures amounts and book values in the financial statements
2023 | |||||
Items subject to: | |||||
Total | Credit risk | Securitization | Counterparty | Market risk | |
Amounts expressed in MMCLP | credit risk | ||||
Amount corresponding to the book | |||||
value of assets in the regulatory | 70,759,228 | 57,518,622 | - | 3,446,909 | 8,891,344 |
consolidation group (as per form LI1) | |||||
(net of provisions) | |||||
Amount corresponding to the book | |||||
value of liabilities in the regulatory | 26,959,900 | 40,282 | - | 2,466,767 | 24,452,851 |
consolidation group (according to | |||||
form LI1) | |||||
Total net amount in the regulatory | 43,799,328 | 57,478,340 | - | 980,143 | -15,561,506 |
consolidation group (row 1 - row 2) | |||||
Amount of off-balance sheet items | 2,604,512 | 2,604,512 | - | - | - |
Valuation differences | - | - | - | - | - |
Differences due to different netting | - | - | - | - | - |
rules, except those included in row 2 | |||||
Differences due to consideration of | - | - | - | - | - |
provisions | |||||
Other (regulatory addon) | -7,278,106 | -7,278,106 | - | - | - |
Amount of exposures for regulatory | 39,125,734 | 52,804,746 | - | 980,143 | -15,561,506 |
purposes | |||||
5
Pillar III - 2Q2023
KM1- Key Parameters
6
Pillar III - 2Q2023
OV1- RWA Presenta on
7
Pillar III - 2Q2023
CC1- Composi on of Regulatory Capital (Part 1)
8
Pillar III - 2Q2023
CC1- Composi on of Regulatory Capital (Part 2)
9
Pillar III - 2Q2023
10
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Banco Santander-Chile published this content on 23 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 April 2024 18:00:06 UTC.